{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T17:34:25Z","timestamp":1697391265884},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T00:00:00Z","timestamp":1193184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s00404-007-0491-5","type":"journal-article","created":{"date-parts":[[2007,10,23]],"date-time":"2007-10-23T09:07:07Z","timestamp":1193130427000},"page":"307-310","source":"Crossref","is-referenced-by-count":4,"title":["First trimester serum inhibin A in normal pregnant women"],"prefix":"10.1007","volume":"277","author":[{"given":"Vorapong","family":"Phupong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tharangrut","family":"Hanprasertpong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sittisak","family":"Honsawek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,24]]},"reference":[{"key":"491_CR1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJM199605093341904","volume":"334","author":"DA Aitken","year":"1996","unstructured":"Aitken DA, Wallace EM, Crossley JA, Swanston IA, van Pareren Y, van Maarle M, Groome NP, Macri JN, Connor JM (1996) Dimeric inhibin A as a marker for Down\u2019s syndrome in early pregnancy. N Engl J Med 334:1231\u20131236","journal-title":"N Engl J Med"},{"key":"491_CR2","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0015-0282(03)02215-5","volume":"80","author":"M Al-Azemi","year":"2003","unstructured":"Al-Azemi M, Ledger WL, Diejomaoh M, Mousa M, Makhseed M, Omu A (2003) Measurement of inhibin A and inhibin pro-alphaC in early human pregnancy and their role in the prediction of pregnancy outcome in patients with recurrent pregnancy loss. Fertil Steril 80:1473\u20131479","journal-title":"Fertil Steril"},{"key":"491_CR3","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1210\/jcem.82.5.3934","volume":"82","author":"M Birdsall","year":"1997","unstructured":"Birdsall M, Ledger W, Groome N, Abdalla H, Muttukrishna S (1997) Inhibin A and activin A in the first trimester of human pregnancy. J Clin Endocrinol Metab 82:1557\u20131560","journal-title":"J Clin Endocrinol Metab"},{"key":"491_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1071\/RD9890001","volume":"1","author":"HG Burger","year":"1989","unstructured":"Burger HG (1989) Inhibin, a member of a new peptide family. Reprod Fertil Dev 1:1\u201313","journal-title":"Reprod Fertil Dev"},{"key":"491_CR5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1399-0004.2005.00441.x","volume":"68","author":"M Christiansen","year":"2005","unstructured":"Christiansen M, Norgaard-Pedersen B (2005) Inhibin A is a maternal serum marker for Down\u2019s syndrome early in the first trimester. Clin Genet 68:35\u201339","journal-title":"Clin Genet"},{"key":"491_CR6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/gye.16.5.365.372","volume":"16","author":"P Florio","year":"2002","unstructured":"Florio P, Ciarmela P, Luisi S, Palumbo MA, Lambert-Messerlian G, Severi FM, Petraglia F (2002) Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels. Gynecol Endocrinol 16:365\u2013372","journal-title":"Gynecol Endocrinol"},{"key":"491_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mce.2004.02.018","volume":"225","author":"P Florio","year":"2004","unstructured":"Florio P, Luisi S, Ciarmela P, Severi FM, Bocchi C, Petraglia F (2004) Inhibins and activins in pregnancy. Mol Cell Endocrinol 225:93\u2013100","journal-title":"Mol Cell Endocrinol"},{"key":"491_CR8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.fertnstert.2003.08.008","volume":"81","author":"P Florio","year":"2004","unstructured":"Florio P, Luisi S, D\u2019Antona D, Severi FM, Rago G, Petraglia F (2004) Maternal serum inhibin A levels may predict pregnancy outcome in women with threatened abortion. Fertil Steril 81:468\u2013470","journal-title":"Fertil Steril"},{"key":"491_CR9","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1093\/humrep\/13.12.3530","volume":"13","author":"PA Fowler","year":"1998","unstructured":"Fowler PA, Evans LW, Groome NP, Templeton A, Knight PG (1998) A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy. Hum Reprod 13:3530\u20133536","journal-title":"Hum Reprod"},{"key":"491_CR10","first-page":"1471","volume":"81","author":"PJ Illingworth","year":"1996","unstructured":"Illingworth PJ, Groome NP, Duncan WC, Grant V, Tovanabutra S, Baird DT, McNeilly AS (1996) Measurement of circulating inhibin forms during the establishment of pregnancy. J Clin Endocrinol Metab 81:1471\u20131475","journal-title":"J Clin Endocrinol Metab"},{"key":"491_CR11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2004.02.019","volume":"225","author":"GM Lambert-Messerlian","year":"2004","unstructured":"Lambert-Messerlian GM, Pinar H, Laprade E, Tantravahi U, Schneyer A, Canick JA (2004) Inhibins and activins in human fetal abnormalities. Mol Cell Endocrinol 225:101\u2013108","journal-title":"Mol Cell Endocrinol"},{"key":"491_CR12","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/oxfordjournals.humrep.a138765","volume":"9","author":"S Muttukrishna","year":"1994","unstructured":"Muttukrishna S, Fowler PA, Groome NP, Mitchell GG, Robertson WR, Knight PG (1994) Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin. Hum Reprod 9:1634\u20131642","journal-title":"Hum Reprod"},{"key":"491_CR13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2265.1995.tb02648.x","volume":"42","author":"S Muttukrishna","year":"1995","unstructured":"Muttukrishna S, George L, Fowler PA, Groome NP, Knight PG (1995) Measurement of serum concentrations of inhibin-A (alpha-beta A dimer) during human pregnancy. Clin Endocrinol (Oxf) 42:391\u2013397","journal-title":"Clin Endocrinol (Oxf)"},{"key":"491_CR14","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/humrep\/17.12.3072","volume":"17","author":"S Muttukrishna","year":"2002","unstructured":"Muttukrishna S, Jauniaux E, Greenwold N, McGarrigle H, Jivraj S, Carter S, Elgaddal S, Groome N, Regan L (2002) Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages. Hum Reprod 17:3072\u20133078","journal-title":"Hum Reprod"},{"key":"491_CR15","first-page":"227","volume":"95","author":"MG Phipps","year":"2000","unstructured":"Phipps MG, Hogan JW, Peipert JF, Lambert-Messerlian GM, Canick JA, Seifer DB (2000) Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies. Obstet Gynecol 95:227\u2013231","journal-title":"Obstet Gynecol"},{"key":"491_CR16","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.fertnstert.2004.11.072","volume":"83","author":"A Prakash","year":"2005","unstructured":"Prakash A, Laird S, Tuckerman E, Li TC, Ledger WL (2005) Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage. Fertil Steril 83:1758\u20131763","journal-title":"Fertil Steril"},{"key":"491_CR17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1210\/edrv.23.2.0459","volume":"23","author":"FM Reis","year":"2002","unstructured":"Reis FM, D\u2019Antona D, Petraglia F (2002) Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr Rev 23:230\u2013257","journal-title":"Endocr Rev"},{"key":"491_CR18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2265.2004.02005.x","volume":"60","author":"EM Wallace","year":"2004","unstructured":"Wallace EM, Marjono B, Tyzack K, Tong S (2004) First trimester levels of inhibins and activin A in normal and failing pregnancies. Clin Endocrinol (Oxf) 60:484\u2013490","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-007-0491-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-007-0491-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-007-0491-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:44:52Z","timestamp":1559065492000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-007-0491-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,24]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["491"],"URL":"https:\/\/doi.org\/10.1007\/s00404-007-0491-5","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,24]]}}}